loadpatents
name:-0.048130035400391
name:-0.042082071304321
name:-0.0070538520812988
THENNATI; Rajamannar Patent Filings

THENNATI; Rajamannar

Patent Applications and Registrations

Patent applications and USPTO patent grants for THENNATI; Rajamannar.The latest application filed is for "anti-inflammatory compounds for use in the treatment of dermal disorders".

Company Profile
7.44.59
  • THENNATI; Rajamannar - Vadodara Gujarat
  • Thennati; Rajamannar - Gujarat IN
  • THENNATI; Rajamannar - Baroda IN
  • Thennati; Rajamannar - Mumbai IN
  • Thennati; Rajamannar - Akota IN
  • Thennati; Rajamannar - Tamil Nadu IN
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Anti-inflammatory Compounds For Use In The Treatment Of Dermal Disorders
App 20220296618 - KOTAMRAJU; Srigiridhar ;   et al.
2022-09-22
GLP-1 analogues
Grant 11,447,535 - Thennati , et al. September 20, 2
2022-09-20
Parenteral Unit Dosage Form Of Dihydroergotamine
App 20220226308 - GOYANI; Alpesh ;   et al.
2022-07-21
A Stable Parenteral Dosage Form Of Cetrorelix Acetate
App 20220153802 - Joshi; Jaydip ;   et al.
2022-05-19
Parenteral unit dosage form of dihydroergotamine
Grant 11,304,942 - Goyani , et al. April 19, 2
2022-04-19
GLP-1 analogues
Grant 11,242,373 - Thennati , et al. February 8, 2
2022-02-08
Stable aqueous injectable solution of epinephrine
Grant 11,234,925 - Rana , et al. February 1, 2
2022-02-01
Parenteral Dosage Form Of Amiodarone
App 20220000776 - Kumar; Samarth ;   et al.
2022-01-06
Stable Aqueous Injectable Solution Of Epinephrine
App 20210353531 - Rana; Amar ;   et al.
2021-11-18
Parenteral dosage form of amiodarone
Grant 11,166,911 - Kumar , et al. November 9, 2
2021-11-09
Novel GLP-1 Analogues
App 20210206823 - Thennati; Rajamannar ;   et al.
2021-07-08
GLP-1 analogues
Grant 11,046,744 - Thennati , et al. June 29, 2
2021-06-29
Stable Parenteral Dosage Form Of Cetrorelix Acetate
App 20210121517 - JOSHI; Jaydip ;   et al.
2021-04-29
Novel GLP-1 Analogues
App 20200362007 - Thennati; Rajamannar ;   et al.
2020-11-19
Stable Aqueous Injectable Solution Of Epinephrine
App 20200214974 - RANA; Amar ;   et al.
2020-07-09
Pharmaceutical Composition Of Nilotinib
App 20200163962 - JAHAGIRDAR; Harshal ;   et al.
2020-05-28
Parenteral Unit Dosage Form Of Dihydroergotamine
App 20200108061 - GOYANI; Alpesh ;   et al.
2020-04-09
Parenteral unit dosage form of dihydroergotamine
Grant 10,532,049 - Goyani , et al. Ja
2020-01-14
Novel GLP-1 Analogues
App 20190309040 - Thennati; Rajamannar ;   et al.
2019-10-10
Octreotide injection
Grant 10,342,850 - Rana , et al. July 9, 2
2019-07-09
Linaclotide stable composition
Grant 10,272,131 - Thennati , et al.
2019-04-30
Parenteral Dosage Form Of Amiodarone
App 20190070110 - KUMAR; Samarth ;   et al.
2019-03-07
Oral pharmaceutical dosage forms of budesonide
Grant 10,172,802 - Thennati , et al. J
2019-01-08
Octreotide Injection
App 20190000918 - RANA; Amar ;   et al.
2019-01-03
Pharmaceutical Compositions Of Dimethyl Fumarate
App 20180369183 - THENNATI; Rajamannar ;   et al.
2018-12-27
Salts of nilotinib and polymorphs thereof
Grant 10,138,221 - Thennati , et al. Nov
2018-11-27
Octreotide Injection
App 20180325993 - RANA; Amar ;   et al.
2018-11-15
Pharmaceutical compositions of dimethyl fumarate
Grant 10,085,961 - Thennati , et al. October 2, 2
2018-10-02
Stable Crystalline Form Of Regadenoson
App 20180208622 - THENNATI; Rajamannar ;   et al.
2018-07-26
Composition Of Iron Sucrose And Process For Its Preparation
App 20180147238 - THENNATI; Rajamannar ;   et al.
2018-05-31
Oral Pharmaceutical Dosage Forms Of Budesonide
App 20170281556 - Thennati; Rajamannar ;   et al.
2017-10-05
Method Of Administering Divalproex
App 20170273923 - Suhagiya; Vishal ;   et al.
2017-09-28
Linaclotide Stable Composition
App 20170232058 - Thennati; Rajamannar ;   et al.
2017-08-17
Novel Salts Of Nilotinib And Polymorphs Thereof
App 20170233372 - THENNATI; Rajamannar ;   et al.
2017-08-17
Oral pharmaceutical dosage forms of budesonide
Grant 9,707,182 - Thennati , et al. July 18, 2
2017-07-18
Tazarotene with low dimer impurity for treating acne or psoriasis
Grant 9,688,667 - Thennati , et al. June 27, 2
2017-06-27
Oral Pharmaceutical Dosage Forms Of Budesonide
App 20170071863 - Thennati; Rajamannar ;   et al.
2017-03-16
Pharmaceutical Compositions Of Dimethyl Fumarate
App 20160346393 - THENNATI; Rajamannar ;   et al.
2016-12-01
Tazarotene With Low Dimer Impurity For Treating Acne Or Psoriasis
App 20160304503 - THENNATI; Rajamannar ;   et al.
2016-10-20
Methods for treatment of inflammatory conditions using S-[4-(3-fleuro-3-methylbutyryloxy)but-2-ynyl]6.alpha., 9.alpha.-difluoro-17.alpha.-(furan-2-yl) carbonyloxy-11.beta.-hydroxy-16.alpha.-methyl-3-oxoandrosta-1,4-diene-17.- beta.-carbothioate
Grant 9,458,187 - Patel , et al. October 4, 2
2016-10-04
Process For Preparation Of Abiraterone Acetate
App 20160176915 - Thennati; Rajamannar ;   et al.
2016-06-23
Methods For Treatment Of Inflammatory Conditions Using S-[4-(3- Fluoro-3-methylbutyryloxy) But-2-ynyl] 6alpha, 9alpha-difluoro-17alpha-(furan-2-yl) Carbonyloxy-11beta -hydroxy-16alpha-methyl-3-oxoandrosta-1,4-diene-17beta - Carbothioate
App 20160102117 - Patel; Jiten Ranchhodbhai ;   et al.
2016-04-14
Piperidinyl monocarboxylic acids as S1P1 receptor agonists
Grant 9,266,867 - Capet , et al. February 23, 2
2016-02-23
Cysteinyl leukotriene antagonists
Grant 9,102,665 - Rathod , et al. August 11, 2
2015-08-11
Diarylacetylene hydrazide containing tyrosine kinase inhibitors
Grant 9,024,021 - Sengupta , et al. May 5, 2
2015-05-05
Dicarboxylic acid derivatives as S1P1 receptor agonists
Grant 8,809,539 - Capet , et al. August 19, 2
2014-08-19
11.beta.-hydroxyandrosta-4-ene-3-ones
Grant 8,785,425 - Patel , et al. July 22, 2
2014-07-22
Cysteinyl Leukotriene Antagonists
App 20140155596 - Rathod; Rajendrasinh ;   et al.
2014-06-05
Process for the preparation of morphinane analogues
Grant 8,710,226 - Patel , et al. April 29, 2
2014-04-29
Novel Piperidinyl Monocarboxylic Acids As S1p1 Receptor Agonists
App 20140099316 - Capet; Marc ;   et al.
2014-04-10
Process For The Preparation Of Morphinane Analogues
App 20140031550 - PATEL; Nileshkumar Sureshbhai ;   et al.
2014-01-30
Diarylacetylene Hydrazide Containing Tyrosine Kinase Inhibitors
App 20130296557 - Sengupta; Prabal ;   et al.
2013-11-07
Process for the preparation of morphinane analogues
Grant 8,546,572 - Patel , et al. October 1, 2
2013-10-01
Process for the preparation of chiral beta amino carboxamide derivatives
Grant 8,471,016 - Jadav , et al. June 25, 2
2013-06-25
Process For The Preparation Of Lacosamide
App 20130102811 - Patel; Maheshbhai Mehulkumar ;   et al.
2013-04-25
Process For The Preparation Of Chiral Beta Amino Carboxamide Derivatives
App 20130041150 - Jadav; Kanaksinh Jesingbhai ;   et al.
2013-02-14
Process For Preparing Sulphoxide Compounds
App 20130030186 - Chhabada; Vijay Chhangamal ;   et al.
2013-01-31
Hydrazide containing taxane conjugates
Grant 8,133,888 - Patel , et al. March 13, 2
2012-03-13
Novel Derivatives Of Acyl Cyanopyrrolidines
App 20120040897 - Akolkar; Nakul Pramod ;   et al.
2012-02-16
Process for the preparation of 10,11-dihydro-10-oxo-5H-dibenz[b,f]azepine-5-carboxamide
Grant 7,982,032 - Muthukumaran , et al. July 19, 2
2011-07-19
Novel Hydrazide Containing Taxane Conjugates
App 20110172226 - Patel; Jiten Ranchhodbhai ;   et al.
2011-07-14
Process For The Preparation Of Morphine Analogues
App 20110152527 - Patel; Nileshkumar Sureshbhai ;   et al.
2011-06-23
Novel Dicarboxylic Acid Derivatives As S1p1 Receptor Agonists
App 20100249187 - Capet; Marc ;   et al.
2010-09-30
Novel Prodrugs
App 20100145057 - Thennati; Rajamannar ;   et al.
2010-06-10
Process of preparing desaloratadine
Grant 7,678,908 - Thennati , et al. March 16, 2
2010-03-16
Stable polymorphic forms of an anticonvulsant
Grant 7,667,042 - Natarajan , et al. February 23, 2
2010-02-23
Stable Amorphous Form Of Pemetrexed Disodium
App 20090181990 - Patel; Nileshkumar S. ;   et al.
2009-07-16
Process for preparation of an anitdepressant compound
Grant 7,550,605 - Shantilal Patel , et al. June 23, 2
2009-06-23
Novel 11 Beta-hydroxyandrosta-4-ene-3-ones
App 20090054388 - Patel; Jiten Ranchhodbhai ;   et al.
2009-02-26
Process for preparation of 1-[9H-carbazol-4-yloxy]-3-[{2-(2-(-methoxy)phenoxy)-ethyl}-amino]-propan-- 2-ol
Grant 7,482,471 - Chhabada , et al. January 27, 2
2009-01-27
Regiospecific process for the preparation of 4-[1- (4-cyanophenyl)-1-(1,2,4-triazol-1-yl)methyl] benzonitrile
Grant 7,459,565 - Patel , et al. December 2, 2
2008-12-02
Process for the Preparation of 10,11-Dihydro-10-Oxo-5H-Dibenz[B,F] Azepine-5-Carboxamide
App 20080269480 - Muthukumaran; Mandakini ;   et al.
2008-10-30
Process for preparation of bisphosphonic acid compounds
Grant 7,411,087 - Patel , et al. August 12, 2
2008-08-12
Process for the preparation of phenylcarbamates
Grant 7,385,076 - Patel , et al. June 10, 2
2008-06-10
4-(diarylmethyl)-1-piperazinyl derivatives
Grant 7,297,697 - Midha , et al. November 20, 2
2007-11-20
Process for preparation of an antidepressant compound
App 20070191616 - Patel; Kartik Shantilal ;   et al.
2007-08-16
Synthesis of s-fluoromethyl 6.alpha.,9.alpha.-difluoro-11.beta.-hydroxy-16.alpha.-methyl-17.alpha.-pr- opionyloxy-3-oxoandrosta-1,4-diene-17.beta.-carbothioate
Grant 7,208,613 - Jadav , et al. April 24, 2
2007-04-24
Process for preparation of bisphosphonic acid compounds
App 20060293524 - Patel; Vijaykumar Muljibhai ;   et al.
2006-12-28
A Process For Preparation Of 1-[9h-carbazol-4-yloxy]-3-[{2-(2-(methoxy)phenoxy)-ethyl}-amino]-propan-2- -ol
App 20060270858 - Chhabada; VijayC ;   et al.
2006-11-30
Regiospecific process for the preparation of 4-[1- (4-cyanophenyl)-1-(1,2,4-triazol-1-yl) methyl] benzonitrile
App 20060128775 - Patel; Hetalkumar Virendrabhai ;   et al.
2006-06-15
Process for hydrogenolysis of [1-(3-dimethylamino)propyl)]-1-(4-fluorophenyl)-1,3-dihydro-5-halo-isoben- zofuran acetamido-3-substituted-3-cephem-4-carboxylic acid
Grant 7,019,153 - Borase , et al. March 28, 2
2006-03-28
Preperation of desloratine
App 20060058334 - Thennati; Rajamannar ;   et al.
2006-03-16
Convenient synthesis of s-fluoromethyl 6alpha, 9alpha-difluoro-11beta-hydr- oxy-16alpha-methyl-17alpha-propionyloxy-3-oxoandrosta-1,4-diene-17beta-car- bothioate
App 20050256325 - Jadav, Kanaksinh ;   et al.
2005-11-17
4-(diarylmethyl)-1-piperazinyl derivatives
App 20050107393 - Midha, Ajay Sohanlal ;   et al.
2005-05-19
Novel process for the preparation of substantially pure 5-(3,5-dimethylphenoxy)methyl-2-oxazolidinone
App 20050075505 - Gandhi, Biren Jaiprakash ;   et al.
2005-04-07
Process for hydrogenolysis of [1-(3-dimethylamino)propyl)]-1-(4-fluorophen- yl)-1,3-dihydro-5-halo-isobenzofuran acetamido]-3-substituted-3-cephem-4-c- arboxylic acid
App 20050004380 - Borase, Ashok Punju ;   et al.
2005-01-06
Process for the preparation of polymorph of 4-(aryl)-1,2,3,4-tetrahydro-1-- naphthale-namine derivative
App 20030149306 - Chitturi, Trinadha Rao ;   et al.
2003-08-07
Method for the preparation of piperazine and its derivatives
Grant 6,603,003 - Sebastian , et al. August 5, 2
2003-08-05
Process for converting stereoisomers of sertraline into sertraline
Grant 6,506,940 - Jadav , et al. January 14, 2
2003-01-14
Novel method for the preparation of piperazine and its derivatives
App 20020095038 - Sebastian, Sonny ;   et al.
2002-07-18

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed